This is a message on behalf of Biomere, as an ACT Corporate Partner benefit.
April 11, 2022 • JOINN INNOVATION PARK • 2600 Hilltop Drive • Richmond, CA
Join Biomere for a 1-day west coast preclinical research symposium fortified by the following subject matter experts:
Current Gene Therapy Trends
Dr. Guangping Gao, PhD
Professor in Biomedical Research
University of Massachusetts Medical School
Best Practices Navigating the IND Process
Dr. Harriet Kamendi, PhD
Consultant
The Design, Conduct, and Interpretation of Nonclinical Ophthalmology Studies Ensuring Regulatory Success
- Low Molecular Weight Molecules & Biotherapeutics
- Gene and Cell Therapies
Dr. Vito Sasseville, DVM, PhD, Dipl. ACVP
PCS Therapeutic Area Head, Ophthalmology and NITD
Novartis Institutes for BioMedical Research
Dr. Mark Milton, MSc, PhD
Global Head, Gene Therapy Therapeutic Area
Novartis Pharmacokinetic Sciences
Visual Specializations within and across Species
Dr. Michael Tri H. Do, PhD
Associate Professor
Harvard Medical School and Boston Children's Hospital
Production and Verifications of MPTP Induced Parkinson's Disease in Non-human Primates
Dr. Crusoe Nan, MD, PhD, DABT
Chief of Neuropharmacology
JOINN Laboratories (Suzhou, China)
INCLUDED IN THE PROGRAM
Breakfast / Lunch provided
Tour of Biomere-West facility (optional)
Berkeley harbor dinner cruise w/transportation (optional)
View Program Agenda and Register at https://biomere.com/symposium/
In-person attendance is limited. Virtual attendance is unlimited.
Contact: Deborah Curry - dcurry@biomere.com